Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery
- PMID: 37973358
- DOI: 10.1016/j.ccc.2023.06.002
Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery
Abstract
Vasoplegic shock after cardiac surgery is characterized by hypotension, a high cardiac output, and vasodilation. Much of the understanding of this pathologic state is informed by the understanding of septic shock. Adverse outcomes and mortality are increased with vasoplegic shock. Early recognition and a systematic approach to its management are critical. The need for vasopressors to sustain an adequate blood pressure as well as pharmacologic adjuncts to mitigate the inflammatory inciting process are necessary. The rationale behind vasopressor escalation and consideration of adjuncts are discussed.
Keywords: Steroids; Vasodilatory shock; Vasoplegia; Vasopressors.
Copyright © 2023 Elsevier Inc. All rights reserved.
Similar articles
-
Methylene Blue: Magic Bullet for Vasoplegia?Anesth Analg. 2016 Jan;122(1):194-201. doi: 10.1213/ANE.0000000000001045. Anesth Analg. 2016. PMID: 26678471 Review.
-
Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.J Cardiothorac Vasc Anesth. 2021 Jan;35(1):51-58. doi: 10.1053/j.jvca.2020.08.001. Epub 2020 Aug 7. J Cardiothorac Vasc Anesth. 2021. PMID: 32868152 Clinical Trial.
-
[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25. Rev Med Chil. 2011. PMID: 21879171 Review. Spanish.
-
Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.AACN Adv Crit Care. 2021 Jun 15;32(2):137-145. doi: 10.4037/aacnacc2021299. AACN Adv Crit Care. 2021. PMID: 34161970 Review.
-
Vasopressin in Vasodilatory Shock.Crit Care Clin. 2019 Apr;35(2):247-261. doi: 10.1016/j.ccc.2018.11.004. Epub 2019 Jan 23. Crit Care Clin. 2019. PMID: 30784607 Review.
Cited by
-
Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation.JACC Adv. 2024 Mar 26;3(5):100916. doi: 10.1016/j.jacadv.2024.100916. eCollection 2024 May. JACC Adv. 2024. PMID: 38939630 Free PMC article.
-
Cardiotoxic Effects Produced by Omeprazole and Methylene Blue in an Animal Model of Cardiac Ischemia and Reperfusion and Potential Implications for the Pharmacological Strategy for Vasoplegic Syndrome.Biomedicines. 2024 Mar 6;12(3):582. doi: 10.3390/biomedicines12030582. Biomedicines. 2024. PMID: 38540195 Free PMC article.
-
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.JTCVS Open. 2025 Apr 25;25:280-293. doi: 10.1016/j.xjon.2025.04.014. eCollection 2025 Jun. JTCVS Open. 2025. PMID: 40631005 Free PMC article.
-
Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study.J Cardiothorac Surg. 2025 May 22;20(1):234. doi: 10.1186/s13019-025-03486-8. J Cardiothorac Surg. 2025. PMID: 40400032 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical